《业绩》歌礼制药(01672.HK)全年亏损扩至3.01亿人民币

阿斯达克财经
26 Mar

歌礼制药-B(01672.HK) 公布2024年度业绩,收入录得128万人民币(下同),按年下降97.7%。亏损由上年度1.45亿元,扩至3.01亿元,每股亏损30.05分。不派末期息。(de/d)(港股报价延迟最少十五分钟。)

过往派息
公布日期派息事项派息内容
2024/08/30中期业绩无派息
2024/03/25末期业绩无派息
2023/08/22中期业绩无派息
2023/03/20末期业绩无派息

AASTOCKS新闻

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10